CPHI logo
  • Products
  • Suppliers
  • Sourcing Requests
  • 中文站
  • Sign in Join free
Post Sourcing Request Post Sourcing Request Sourcing Request List Exhibition
  • Home
  • Products
  • Suppliers
  • Content Hub
  • Industry Insights
  • Service & Membership
  • E-Trade Season
  • For Suppliers

    My Account

    My Online Store

    My EZSourcing

    View Sourcing Requests

    Customer Service

  • For Buyer

    Search Products & Suppliers

    Products Directory Suppliers Discovery Post EZSourcing

    Service

    Buyer Sourcing Event Contact Us

    Quick links

    My Favorites Recent Visit History
  • Industry Data
  • Features
  • Market News
  • Products Guide
  • Brand Story
You are here:   Industry Insights > Industry Data

Industry Data

  • Pharma News Review of PharmaSources (February) - Business Industry Data Caicai/PharmaSourcesMarch 14, 2023
    On the business, Keymed Biosciences Inc. and Lepu Biopharma jointly announced an exclusive global licensing agreement with AstraZeneca for CMG901. In terms of the listing, Kelun Pharmaceutical's subsidiary Kelun Biotech intends to go public in Hong Kong.
  • Monthly Pharma News Review of PharmaSources (February) - Chinese Drug review and approval Industry Data Caicai/PharmaSourcesMarch 14, 2023
    The anti-PD-L1 monoclonal antibody Adebrelimab from Hengrui Pharmaceuticals was approved for marketing, and the Class 3 chemotherapy Limaprost tablets from Sino Biopharm were approved for marketing.
  • Monthly News Review of PharmaSources (February) - R&D Industry Data Caicai/PharmaSourcesMarch 13, 2023
    In R&D​, Chipscreen chidamide Ⅲ test reaches preset indicators, the company plans to submit an application for the marketing of a new indication.
  • The Accepted Marketing Application of Roche's Glofitamab in China Industry Data Yefenghong/PharmaSourcesMarch 01, 2023
    Recently, the marketing application of Roche's Glofitamab has been accepted by NMPA in China.
  • The R&D of CD20/CD3 Bispecific Antibody in China Industry Data Yefenghong/PharmaSourcesMarch 01, 2023
    Currently, the R&D of CD20/CD3 bispecific antibody is still in the early stage. In China, few CD20/CD3 bispecific antibodies have entered the clinical stage, among which GB261 from Genor Biopharma has a good progress.
  • The Performance of the Two Insulin Companies on Volumn-based Procurement in the First Year Industry Data Yefenghong/PharmaSourcesMarch 01, 2023
    Two leaders of insulin made in China, Tonghua Dongbao and Gan & Lee Pharmaceuticals, has announced their performance in 2022 respectively. As the first year of centralized procurement of insulin, two companies' performance both declined in 2022.
  • The Coming Successor and the Ending Humira Industry Data Yi/PharmaSourcesMarch 01, 2023
    On January 31, Amgen announced that its Humira (Adalimumab) biosimilar, Amjevita (adalimumab-atto), had entered into the American market officially.And Amjevita is also the first adalimumab biosimilar approved by FDA.
  • First Generic Drugs Approved in China in 2022 Industry Data Zhulikou/PharmaSourcesFebruary 15, 2023
    List of the First Generic Drugs Approved in China in 2022
  • Weekly Pharma News Review | PharmaSources.com (Feb.6th - 10th, 2023) Industry Data CaicaiFebruary 13, 2023
    A new indication of Pfizer's tofacitinib sustained release tablet was approved in China; Phase III study of obesity indication of Eli Lilly's Tirzepatide succeeded in China.
  • A Glimpse of the Capacity and Supply of Blood Products Made in China Industry Data XiaoyaowanFebruary 08, 2023
    Gamma globulin is the passive immunity preparation, of which the most widely used product in the clinical practice is the human immunoglobulin for intravenous injection, referred to PH4.
Previous page 1 2 3 4 5 6 7 8 ... 37 38 Next page

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
  • Copyright 2006-2023 Shanghai Sinoexpo Informa Markets International Exhibition Co. Ltd (All Rights Reserved) 沪ICP备05034851号-182
  • Links:
    CCCMHPIE SJGLE.com JJGLE.COM JDGLE.COM XIUGLE.COM DENGGLE.COM HPGLE.COM
  • Follow Us:

  • CPHI logo Pharma Sources Insight JUNE2022
  • PharmaSources@imsinoexpo.com
  • +86-13621645194
  • We Want Your Feedback